Lobeglitazone Completed Phase 2 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01030679Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus